[ORGANIZATION]
Enveda
Featured in 6 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
320 clusters · 1171 sources · last updated
Latest: GLP-1 weight-loss drugs may exacerbate eating disorders
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. However, safety concerns are
Sarcopenia Prevention and Muscle-Preserving Trends
19 clusters · 59 sources · last updated
Latest: Sarcopenia prevention requires combining protein with strength training
By late October 2026, medical focus has intensified on managing sarcopenia, the progressive loss of muscle mass and strength that typically accelerates after age 50 or 60. A significant clinical challenge exists for pati